Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers

Overview

Journal Anal Cell Pathol (Amst)

Specialties Cell Biology
Oncology
Pathology

Date 2020 May 8

PMID 32377504

Citations 69

Authors

Rui Wei

Si Liu

Shutian Zhang

Li Min

Shengtao Zhu

Affiliations

Soon will be listed here.

Abstract

Tumors are surrounded by complex environmental components, including blood and lymph vessels, fibroblasts, endothelial cells, immune cells, cytokines, extracellular vesicles, and extracellular matrix. All the stromal components together with the tumor cells form the tumor microenvironment (TME). In addition, extracellular physical and chemical factors, including extracellular pH, hypoxia, elevated interstitial fluid pressure, and fibrosis, are closely associated with tumor progression, metastasis, immunosuppression, and drug resistance. Cellular and extracellular components in TME contribute to nearly all procedures of carcinogenesis. By summarizing the recent work in this field, we make a comprehensive review on the role of cellular and extracellular components in the process of carcinogenesis and their potential application in early diagnosis of cancer. We hope that a systematic review of the diverse aspects of TME will help both research scientists and clinicians in this field.

Citing Articles

Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance.

Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M Med Oncol. 2025; 42(4):108.

PMID: 40087196 DOI: 10.1007/s12032-025-02675-8.

Role of amino acid metabolism in tumor immune microenvironment of colorectal cancer.

Zhu M, Hu Y, Gu Y, Lin X, Jiang X, Gong C Am J Cancer Res. 2025; 15(1):233-247.

PMID: 39949925 PMC: 11815375. DOI: 10.62347/ZSOO2247.

Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma.

Shan Y, He D, Yan F, Huang W Front Immunol. 2025; 15():1522820.

PMID: 39830511 PMC: 11739722. DOI: 10.3389/fimmu.2024.1522820.

Expression of Lumican and Osteopontin in Perivascular Areas of the Glioblastoma Peritumoral Niche and Its Value for Prognosis.

Salinas M, Rodriguez P, Rubio G, Valdor R Int J Mol Sci. 2025; 26(1.

PMID: 39796053 PMC: 11720198. DOI: 10.3390/ijms26010192.

Identification of immunogenic cell death gene-related subtypes and risk model predicts prognosis and response to immunotherapy in ovarian cancer.

Pan W, Jia Z, Zhao X, Chang K, Liu W, Tan W PeerJ. 2024; 12:e18690.

PMID: 39686988 PMC: 11648682. DOI: 10.7717/peerj.18690.

References

Zips D, Zophel K, Abolmaali N, Perrin R, Abramyuk A, Haase R . Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol. 2012; 105(1):21-8. DOI: 10.1016/j.radonc.2012.08.019. View

Wang S, Jia J, Liu D, Wang M, Wang Z, Li X . Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome. Sci Rep. 2019; 9(1):11677. PMC: 6691000. DOI: 10.1038/s41598-019-47871-5. View

Peppicelli S, Andreucci E, Ruzzolini J, Laurenzana A, Margheri F, Fibbi G . The acidic microenvironment as a possible niche of dormant tumor cells. Cell Mol Life Sci. 2017; 74(15):2761-2771. PMC: 11107711. DOI: 10.1007/s00018-017-2496-y. View

Koukourakis M, Giatromanolaki A, Harris A, Sivridis E . Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 2006; 66(2):632-7. DOI: 10.1158/0008-5472.CAN-05-3260. View

Li Y, Zhang D, Wang X, Yao X, Ye C, Zhang S . Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer. Sci Rep. 2015; 5:12495. PMC: 4513346. DOI: 10.1038/srep12495. View

Ohmura Y, Yoshikawa K, Saga S, Ueda R, Kazaoka Y, Yamada S . Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy. Oncol Rep. 2008; 19(5):1265-70. View

Libutti S, Tamarkin L, Nilubol N . Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure. Oncotarget. 2018; 9(87):35723-35725. PMC: 6254664. DOI: 10.18632/oncotarget.26267. View

Bhangu J, Taghizadeh H, Braunschmid T, Bachleitner-Hofmann T, Mannhalter C . Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden. Surg Oncol. 2017; 26(4):395-401. DOI: 10.1016/j.suronc.2017.08.001. View

Vaupel P, Kallinowski F, Okunieff P . Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989; 49(23):6449-65. View

10.

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

11.

Webb B, Chimenti M, Jacobson M, Barber D . Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer. 2011; 11(9):671-7. DOI: 10.1038/nrc3110. View

12.

Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E . In search of definitions: Cancer-associated fibroblasts and their markers. Int J Cancer. 2019; 146(4):895-905. PMC: 6972582. DOI: 10.1002/ijc.32193. View

13.

Muller C . Tumour-surrounding adipocytes are active players in breast cancer progression. Ann Endocrinol (Paris). 2013; 74(2):108-10. DOI: 10.1016/j.ando.2013.02.007. View

14.

Matsushita H, Hosoi A, Ueha S, Abe J, Fujieda N, Tomura M . Cytotoxic T lymphocytes block tumor growth both by lytic activity and IFNγ-dependent cell-cycle arrest. Cancer Immunol Res. 2014; 3(1):26-36. DOI: 10.1158/2326-6066.CIR-14-0098. View

15.

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

16.

Chan D, Kawahara T, Sutphin P, Chang H, Chi J, Giaccia A . Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell. 2009; 15(6):527-38. PMC: 2846696. DOI: 10.1016/j.ccr.2009.04.010. View

17.

Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y . Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019; 21(4):498-510. DOI: 10.1038/s41556-019-0299-0. View

18.

McBride J, Rodriguez-Menocal L, Badiavas E . Extracellular Vesicles as Biomarkers and Therapeutics in Dermatology: A Focus on Exosomes. J Invest Dermatol. 2017; 137(8):1622-1629. DOI: 10.1016/j.jid.2017.04.021. View

19.

Peppicelli S, Ruzzolini J, Bianchini F, Andreucci E, Nediani C, Laurenzana A . Anoikis Resistance as a Further Trait of Acidic-Adapted Melanoma Cells. J Oncol. 2019; 2019:8340926. PMC: 6582804. DOI: 10.1155/2019/8340926. View

20.

Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. DOI: 10.1016/j.cell.2005.02.034. View